Vaginal Neoplasms

• 

  Subject Areas on Research

  • 5-day methotrexate for women with metastatic gestational trophoblastic disease. 
  • A Gartner Duct Cyst Masquerading as Anterior Vaginal Prolapse. 
  • Adenosis and clear-cell carcinoma of the vagina. An invitational sympotium. Introduction. 
  • Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. 
  • Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. 
  • Benign vaginal rhabdomyoma: a light and electron microscopic study. 
  • Bizarre leiomyoma of the posterior vaginal fornix. 
  • Cancer risk in women exposed to diethylstilbestrol in utero. 
  • Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. 
  • Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol. 
  • Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. 
  • Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. 
  • Clinicopathologic study of 85 cases of melanoma of the female genitalia. 
  • Comparison of histologic and colposcopic findings in DES-exposed females. 
  • Complications of prenatal therapy with diethylstilbestrol. 
  • Cytologic screening after hysterectomy for benign disease. 
  • Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. 
  • Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. 
  • Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project. 
  • Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. 
  • Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. 
  • Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. 
  • Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis. 
  • Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). 
  • Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. 
  • Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions. 
  • Measuring the significance of field validation in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology: how good are the experts? 
  • Microglandular hyperplasia in vaginal adenosis associated with oral contraceptives and prenatal diethylstilbestrol exposure. 
  • Mucinous adenocarcinoma arising in rectovaginal fistulas associated with Crohn's disease. 
  • Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. 
  • Nuclear DNA content of clear cell adenocarcinoma of the vagina and cervix and its relationship to prognosis. 
  • Nuclear DNA study of vaginal and cervical squamous cell abnormalities in DES exposed progeny. 
  • Pathologic findings in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project. 
  • Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des). 
  • Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies. 
  • Prenatal diethylstilbestrol exposure and human genital tract abnormalities. 
  • Radiotherapy alone for carcinoma of the vagina: the importance of overall treatment time. 
  • Role of hormones including diethylstibestrol (DES) in the pathogenesis of cervical and vaginal intraepithelial neoplasia. 
  • Selected topics in the pathology of the vagina. 
  • Soft tissue complication rates after low dose rate brachytherapy using customized perineal templates. 
  • Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol. 
  • Stage 1 small cell cancer of the vagina. 
  • Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. 
  • The effects of local progesterone on stilbestrol-associated vaginal adenosis. 
  • The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females. 
  • Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma. 
  • Ultrastructure of 16 cases of clear cell adenocarcinoma of the vagina and cervix in young women. 
  • Vaginal adenosis and other diethylstilbestrol-related abnormalities. 
  • Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology